The Delhi High Court yesterday gave the go-ahead to Bangalore-based pharma company Biocon and US-based Mylan Inc. to manufacture and sell their biosimilar drugs for the treatment of early breast cancer and metastatic gastric cancer.
We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.